The diverse functions of immune cells in the body are extremely rigorously controlled in order to combat infections. How Toxoplasma infects so many people and animal species and spreads so quickly has long been a mystery to scientists.
A new drug combination has been found to be more effective, especially against persistent, drug-resistant infections, according to an international study led by a Rutgers scientist comparing new and older treatments for complicated urinary tract infections.
A combination of the drugs cefepime and enmetazobactam was more effective in treating both complicated urinary tract infections and acute pyelonephritis (AP), a bacterial infection causing kidney inflammation than a standard treatment combining piperacillin and tazobactam.
Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.
Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new research.
A new study from scientists at La Jolla Institute for Immunology gives researchers a guide to neutralizing Lassa virus using a trio of rare antibodies isolated from survivors of Lassa virus infection.
The body's response to infection or inflammation is fever, which also serves as a defence mechanism against things like viruses and bacteria. The body releases molecules called cytokines into the bloodstream when it is infected or inflammatory. The blood-brain barrier, a system of microscopi
A combination of the drugs cefepime and enmetazobactam was more effective in treating both complicated urinary tract infections and acute pyelonephritis (AP), a bacterial infection causing kidney inflammation, than a standard treatment combining piperacillin and tazobactam.
An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially against stubborn, drug-resistant infections.
Recently published research found that blood transfusion is associated with adverse outcomes - including infection and higher rates of tumor recurrence - in pediatric solid tumor oncology patients following surgical removal of the tumor.